Wellington Management Group
ADVM

Wellington Management Group’s Adverum Biotechnologies ADVM Stock Holding History

Wellington Management Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-247,533
Closed -$24.4M – 2121
2021
Q1 		$24.4M Sell
247,533
-20,749
-8% -$2.49M ﹤0.01% 1018
2020
Q4 		$29.1M Buy
268,282
+40,823
+18% +$5.05M 0.01% 948
2020
Q3 		$23.4M Buy
227,459
+103,523
+84% +$15.5M ﹤0.01% 917
2020
Q2 		$25.9M Buy
+123,936
New +$22M 0.01% 871
2020
Q1 		– Sell
-24,261
Closed -$2.79M – 1894
2019
Q4 		$2.79M Buy
+24,261
New +$2.14M ﹤0.01% 1473
2015
Q2 		– Sell
-37,927
Closed -$15.4M – 2130
2015
Q1 		$15.4M Buy
+37,927
New +$16M ﹤0.01% 1122

Other funds holding ADVM

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group's ADVM Position: Q2 2021 in Review

Wellington Management Group sold out of Adverum Biotechnologies (ADVM) in Q2 2021, closing a stake of 247,533 shares — an estimated $24.4M sold.

Wellington Management Group first reported a position in ADVM in Q1 2015 and held it in 6 quarters. The position peaked at $29.1M in Q4 2020. 118 funds tracked by Wall St. Rank hold ADVM as of Q2 2021.

  • Wellington Management Group reported no remaining Adverum Biotechnologies position as of Q2 2021 after selling out during the quarter.
  • Wellington Management Group sold 247,533 Adverum Biotechnologies shares in Q2 2021, an estimated $24.4M.
  • Wellington Management Group first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 6 quarters.
  • Wellington Management Group's Adverum Biotechnologies position peaked at $29.1M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2021.

Based on Wellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.